Home
Center for Diabetes Research

Other International, Peer-Reviewed Journals 2012

Main content

2012

  • Ræder H, Molven A, Njølstad PR. [Tailored medicine or narcissomics?]. Tidsskr Nor Laegeforen. 2012 Sep 4;132(16):1844-5.
  • Negahdar M, Aukrust I, Johansson BB, Molnes J, Molven A, Matschinsky FM, Søvik O, Kulkarni RN, Flatmark T, Njølstad PR, Bjørkhaug L. GCK-MODY diabetes associated with protein misfolding, cellular self-association and degradation. Biochim Biophys Acta. 2012 Nov;1822(11):1705-15.
  • Johansson S, Irgens H, Chudasama KK, Molnes J, Aerts J, Roque FS, Jonassen I, Levy S, Lima K, Knappskog PM, Bell GI, Molven A, Njølstad PR. Exome sequencing and genetic testing for MODY. PLoS One. 2012;7(5):e38050.
  • Gonc EN, Ozturk BB, Haldorsen IS, Molnes J, Immervoll H, Raeder H, Molven A, Søvik O, Njølstad PR. HNF1B mutation in a Turkish child with renal and exocrine pancreas insufficiency, diabetes and liver disease. Pediatr Diabetes. 2012 Mar;13(2):e1-5.
  • Søvik O, Aagenaes O, Eide SÅ, Mackay D, Temple IK, Molven A, Njølstad PR. Familial occurrence of neonatal diabetes with duplications in chromosome 6q24: treatment with sulfonylurea and 40-yr follow-up. Pediatr Diabetes. 2012 Mar;13(2):155-62.
  • Viste K, Mellgren G. [The ubiquitous receptors]. Tidsskr Nor Laegeforen. 2012 Dec 11;132(23-24):2585.
  • Moi LL, Flågeng MH, Gjerde J, Madsen A, Røst TH, Gudbrandsen OA, Lien EA, Mellgren G. Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer. BMC Cancer. 2012 Jun 15;12:247.
  • Gjerde J, Gandini S, Guerrieri-Gonzaga A, Haugan Moi LL, Aristarco V, Mellgren G, Decensi A, Lien EA. Tissue distribution of 4-hydroxy-N-desmethyltamoxifen and tamoxifen- N-oxide. Breast Cancer Res Treat. 2012 Jul;134(2):693-700.
  • Veum VL, Dankel SN, Gjerde J, Nielsen HJ, Solsvik MH, Haugen C, Christensen BJ, Hoang T, Fadnes DJ, Busch C, Våge V, Sagen JV, Mellgren G. The nuclear receptors NUR77, NURR1 and NOR1 in obesity and during fat loss. Int J Obes (Lond). 2012 Sep;36(9):1195-202
  • Borgeraas H, Strand E, Ringdal Pedersen E, Dierkes J, Ueland PM, Seifert R, Wilberg ER, Bohov P, Berge RK, Nilsen DW, Nygård O. Omega-3 Status and the Relationship between Plasma Asymmetric Dimethylarginine and Risk of Myocardial Infarction in Patients with Suspected Coronary Artery Disease. Cardiol Res Pract. 2012;2012:201742.
  • Vigerust NF, Bohov P, Bjørndal B, Seifert R, Nygård O, Svardal A, Glintborg D, Berge RK, Gaster M. Free carnitine and acylcarnitines in obese patients with polycystic ovary syndrome and effects of pioglitazone treatment. Fertil Steril. 2012 Dec;98(6):1620-6.e1.
  • Strand E, Bjorndal B, Nygard O, Burri L, Berge C, Bohov P, Christensen BJ, Berge K, Wergedahl H, Viste A, Berge RK. Long-term treatment with the pan-PPAR agonist tetradecylthioacetic acid or fish oil is associated with increased cardiac content of n-3 fatty acids in rat. Lipids Health Dis. 2012 Jun 27;11:82.
  • Vikøren LA, Nygård OK, Lied E, Rostrup E, Gudbrandsen OA. A randomised study on the effects of fish protein supplement on glucose tolerance, lipids and body composition in overweight adults. Br J Nutr. 2013 Feb 28;109(4):648-57.
  • Nilsen RM, Bjørke-Monsen AL, Midttun O, Nygård O, Pedersen ER, Ulvik A, Magnus P, Gjessing HK, Vollset SE, Ueland PM. Maternal tryptophan and kynurenine pathway metabolites and risk of preeclampsia. Obstet Gynecol. 2012 Jun;119(6):1243-50.
  • Bjørndal B, Vik R, Brattelid T, Vigerust NF, Burri L, Bohov P, Nygård O, Skorve J, Berge RK. Krill powder increases liver lipid catabolism and reduces glucose mobilization in tumor necrosis factor-alpha transgenic mice fed a high-fat diet. Metabolism. 2012 Oct;61(10):1461- 72.
  • Jugessur A, Skare Ø, Lie RT, Wilcox AJ, Christensen K, Christiansen L, Nguyen TT, Murray JC, Gjessing HK. X-linked genes and risk of orofacial clefts: evidence from two population-based studies in Scandinavia. PLoS One. 2012;7(6):e39240.
  • Skare O, Jugessur A, Lie RT, Wilcox AJ, Murray JC, Lunde A, Nguyen TT, Gjessing HK. Application of a novel hybrid study design to explore gene-environment interactions in orofacial clefts. Ann Hum Genet. 2012 May;76(3):221-36.
  • Shi M, Murray JC, Marazita ML, Munger RG, Ruczinski I, Hetmanski JB, Wu T, Murray T, Redett RJ, Wilcox AJ, Lie RT, Jabs EW, Wu-Chou YH, Chen PK, Wang H, Ye X, Yeow V, Chong SS, Shi B, Christensen K, Scott AF, Patel P, Cheah F, Beaty TH. Genome wide study of maternal and parent-of-origin effects on the etiology of orofacial clefts. Am J Med Genet A. 2012 Apr;158A(4):784-94.
  • Wehby GL, Murray JC, Wilcox A, Lie RT. Smoking and body weight: evidence using genetic instruments. Econ Hum Biol. 2012 Mar;10(2):113-26.